Patent · US Active

Method to produce an immunoglobulin preparation with improved yield

US8940877B2 · kind B2 · utility

3Cited by

22References

27Claims

0Family size

Assignees

Baxter International Inc. · US
Baxter Healthcare SA · CH

Inventors

Leopold Bruckschwaiger · Wien, AT
Sonja Svatos · Ybbs an der Donau, AT
Julia Nuernberger · Wien, AT
Wolfgang Teschner · Wien, AT
Harald Arno Butterweck · Wien, AT
Hans-Peter Schwarz · Wien, AT
Thomas Gundinger · Wien, AT
Bernhard Koelbl · Achau, AT
Reinhard Grausenburger · Wien, AT
Azra Pljevljakovic · Wien, AT

Key dates

Filing date	Oct 16, 2012
Grant date	Jan 27, 2015
Priority date	—
Expiry date	Oct 16, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K1/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides improved methods for the manufacturing of IVIG products. These methods offer various advantages such as reduced loss of IgG during purification and improved quality of final products. In other aspects, the present invention provides aqueous and pharmaceutical compositions suitable for intravenous, subcutaneous, and/or intramuscular administration. In yet other embodiments, the present invention provides methods of treating a disease or condition comprising administration of an IgG composition provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.